Healthcare

This bill requires the VA and Department of Defense to provide stellate ganglion block therapy to eligible veterans and active-duty military members diagnosed with PTSD who have given informed consent after learning about the treatment's risks and benefits. It applies specifically to veterans enrolled in VA care and service members in the TRICARE program who meet the diagnosis and consent criteria. The bill mandates that VA and DoD update their joint clinical guidelines within 180 days to include this therapy option and its clinical indicators. The policy change takes effect 180 days after enactment, making this therapy a covered benefit through existing VA and military healthcare systems.

This bill, titled "Prison Rape Prevention Act of 2025" (HR 1015), actually establishes rules for housing and medical care in federal prisons, not rape prevention. It requires the Bureau of Prisons to house and transport inmates only with others of the same biological sex (defined by reproductive anatomy) and prohibits providing gender-related medical treatments. This includes banning treatments like hormone therapy, surgeries (e.g., hysterectomy, phalloplasty), or puberty blockers for transgender inmates, except for specific medical conditions like disorders of sex development or injuries from prior treatments. The bill directly affects all federal prison inmates and applies only to the Bureau of Prisons.

HR 2137, the Review Every Veterans Claim Act of 2025, prevents the Department of Veterans Affairs (VA) from denying benefit claims solely because a veteran misses a required medical exam. It amends Section 5103A of Title 38, U.S. Code, to prohibit automatic denials for missed exams and requires the VA to consider other factors. This directly affects veterans filing claims for VA benefits who skip scheduled medical evaluations. The bill ensures veterans cannot be rejected for a claim based only on non-attendance, while allowing denials for other valid reasons.

Stop the Wait Act of 2025 This bill phases out the initial waiting period for Social Security Disability Insurance (SSDI) benefits and eliminates the waiting period for certain disabled individuals to become eligible for Medicare.  Under current law, individuals generally must wait five months after the onset of disability to begin receiving SSDI benefits. The bill would gradually reduce this waiting period before eliminating it entirely in the year 2030.  Further, the bill would eliminate the 24-month waiting period for certain disabled workers and other individuals to become eligible for Medicare. Under current law, individuals under the age of 65 may generally enroll in Medicare after they have been eligible for SSDI or Social Security child’s, widow’s, or widower’s benefits by reason of disability for 24 months. The bill would eliminate this waiting period for individuals for whom the annual cost of certain medical insurance would exceed a specified percentage of their household income (i.e., those who cannot afford minimum essential coverage). Medicare eligibility for these individuals must be available retroactively to the first month that an individual qualified for SSDI or Social Security child’s, widow’s, or widower’s benefits by reason of disability.

This bill creates a 35% refundable tax credit for homeowners making accessibility improvements like ramps, grab bars, bathroom modifications, or adaptive technology to accommodate individuals with disabilities, blindness, or seniors aged 60+. The credit covers up to $10,000 annually ($30,000 lifetime) for qualifying modifications to the primary residence, with income limits reducing eligibility for taxpayers earning over $200,000 ($400,000 for joint filers). It applies to the homeowner or their dependent/spouse who meets specific disability or age criteria, including those receiving disability benefits or having a physician-certified disability. The credit requires documentation and is designed to help people remain safely in their homes without requiring new legislation for future eligibility.

HR 2752, the Ensuring Safer Schools Act of 2025, amends federal grant programs to prioritize hiring veterans and retired law enforcement officers as school resource officers (SROs). The bill requires COPS grants to give preferential consideration for applications focused on recruiting these individuals, adds annual mental health screenings and training for SROs, and defines "veteran or retired law enforcement officer" for grant eligibility. It also mandates coordination between the Department of Veterans Affairs and schools to connect veterans with SRO roles. This directly affects schools receiving COPS grants, veterans seeking SRO positions, and local law enforcement agencies partnering with schools. The law changes how federal funds are administered for school safety roles, not school policies.

The Medical Supply Chain Resiliency Act (HR 2213) establishes a framework for the U.S. to form agreements with foreign countries that commit to reliable medical supply chains during emergencies. It allows the President to negotiate "trusted trade partner agreements" that reduce trade barriers (like duties and quotas) for medical goods with countries meeting specific criteria, such as maintaining open trade during health crises and protecting intellectual property. These agreements require Congressional review and approval, with ongoing monitoring to ensure partners uphold commitments. The bill directly affects U.S. trade policy, foreign governments seeking partnerships, and the medical supply industry by aiming to diversify sources and secure critical products like pharmaceuticals and medical devices.

HR 3658, the 911 Community Crisis Responders Act of 2025, provides federal grants to states, tribes, and local governments to create unarmed mobile crisis response teams. These teams would handle nonviolent 911 calls related to mental health, substance use, homelessness, or disabilities - instead of sending police - by dispatching trained professionals like social workers or nurses. The bill requires grantees to update 911 systems for call triage, train dispatchers to identify appropriate referrals, and collect data on demographics, outcomes (like reduced ER visits), and program costs. It directly affects communities experiencing mental health or substance use crises by offering an alternative to law enforcement responses.

HR 3406, the "Readiness Over Wokeness Act," prohibits individuals with a current diagnosis, history, or symptoms of gender dysphoria, or a history of gender-affirming care (like hormone therapy or surgery), from serving in the U.S. Armed Forces. It requires the military to administratively discharge affected service members, with the key provision that they won’t need to repay educational benefits or fulfill remaining service obligations. The bill also mandates security clearance reinvestigations for those discharged who previously held access to classified information. This policy directly affects transgender and gender-diverse service members who have sought gender-affirming care or received a gender dysphoria diagnosis. The bill focuses on altering military medical standards for service eligibility, not on broader societal or policy changes.

HR 5158, the Fair Price Device Act, amends drug approval rules to require generic drug manufacturers to provide specific evidence when their drug is intended for use with a medical device. It directly affects pharmaceutical companies seeking approval for generic drugs that must be used with a device (like insulin pumps or inhalers). The key provision adds new requirements for applicants to submit comparative data on device compatibility, user interface differences, and human factors studies to prove the generic drug will perform equivalently to the brand-name version when used with the device. This ensures safety and effectiveness are maintained despite potential device variations, without changing the core approval standards for generic drugs.